Hap Trading, LLC Aurinia Pharmaceuticals Inc. Transaction History

Hap Trading, LLC

  • $872 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$12.94 - $16.05 $21,881 - $27,140
-1,691 Reduced 2.6%
63,456 $878,000
Q3 2020

Nov 13, 2020
BUY
$13.19 - $16.66 $365,455 - $461,598
27,707 Added 74.0%
65,147 $960,000
Q1 2020

May 08, 2020
BUY
$11.34 - $21.46 $244,603 - $462,892
21,570 Added 135.92%
37,440 $543,000
Q4 2019

Feb 11, 2020
BUY
$3.88 - $21.42 $61,575 - $339,935
15,870 New
15,870 $322,000

Others Institutions Holding AUPH

# of Institutions
210
Shares Held
58.1M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.13B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email